MascitelliL., RavnskovU., PezzettaF., GoldsteinM.After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with exetimibe.Angiology.2008; 59.
2.
ShepherdJ., CobbeS.M., FordI.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.N Engl J Med.1995; 333: 1301–1307.
3.
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).Lancet.1994; 344: 1383–1389.
4.
The Lipid Research Clinics Coronary Primary Prevention Trial results.I. Reduction in incidence of coronary heart disease.JAMA.1984; 251: 351–364.
5.
The Lipid Research Clinics Coronary Primary Prevention Trial results.II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.JAMA.1984; 251: 365–374.
6.
BuchwaldH., VarcoR.L., BoenJ.R.Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.Arch Intern Med.1998; 158: 1253–1261.
7.
GrundyS.M., CleemanJ.I., MerzC.N.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.Circulation.2004; 110: 227–239.
8.
WiviottS.D., CannonC.P., MorrowD.A., RayK.K., PfefferM.A., BraunwaldE.Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.J Am Coll Cardiol.2005; 46: 1411–1416.
9.
BlankenhornD.H., NessimS.A., JohnsonR.L., SanmarcoM.E., AzenS.P., Cashin-HemphillL.Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.JAMA.1987; 257: 3233–3240.
10.
NissenS., NichollsS.J., SipahiI., ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID Trial.JAMA.2006; 295: 1556–1565.
11.
WangC.Y., LiuP.Y., LiaoJ.K.Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.Trends Mol Med.2008; 14: 37–44.
12.
PetoR., EmbersonJ., LandrayM.Analyses of cancer data from three ezetimibe trials.N Engl J Med.2008; 359: 1357–1366.
